ADVERTISEMENT



Google       
Call (866) 635-2689 for a free Personal Injury evaluation by attorney in your area.

Home -> Law Blog Directory -> Personal Injury Law Blogs -> Drug Injury Watch

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Personal Injury Law

: Drug Injury Watch

Psoriasis Drug Raptiva Alleged To Have Caused Hodgkin's Lymphoma Just Before April 2009 Recall

By Tom Lamb

ADVERTISEMENTS

2011 Raptiva Lawsuit Filed In Texas Against Drug Company: Failure To Warn About Side Effect Risks

(Posted by Tom Lamb at DrugInjuryWatch.com)

Back in 2009, we told you about some of the developments which led to Raptiva being withdrawn from the market in these two articles:

-- A Timeline For The Psoriasis Drug Raptiva, From Product Launch In U.S. To Market Withdrawal (April 2009)

-- FDA Warns About Rare Brain Infection PML Linked To Psoriasis Drug Raptiva (February 2009)

Now, a couple of years later, we have a products liability lawsuit that has been filed in Texas alleging that Raptiva was what caused a psoriasis patient to be diannosed with Hodgkin's lymphoma in March 2009, just a month before the Raptiva recall in the U.S.

From a January 7, 2011 Bloomberg news report, "Roche Sued by Patient Claiming Cancer From Pulled Psoriasis Drug Raptiva", we get these details:

  • Houston-area psoriasis patient Cary Massa, 51, was diagnosed with classic Hodgkin?s lymphoma in March 2009, after taking Raptiva from February 2006 to January 2008, according to a complaint filed today in Houston federal court.
  • The case is Massa v. Genentech Inc. and Xoma (US) LLC, 4:11-cv-00070, U.S. District Court, Southern District of Texas (Houston).
  • Genentech was acquired by Roche Holding in March 2009, the month before the company began pulling Raptiva from the market. The company estimated 2,000 U.S. patients were taking the drug at that time, generating U.S. sales of $108 million in 2008.

We expect that there will be more drug injury lawsuits filed against Roche and Genentech by patients who developed progressive multifocal leukoencephalopathy, or PML, a rare but fatal brain infection -- which was the primary reason Raptive was withdrawn from the market in April 2009 -- as well as other serious side effects such as Hodgkin's lymphoma and other cancers after using Raptiva.

______________________________________________________________________________

DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects

Drug Injury Case Evaluation - Free & Confidential

Full post as published by Drug Injury Watch on January 13, 2011 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Lawsuits and Settlements

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0145 secs (new cache)